Liquidia Technologies (NASDAQ:LQDA) Reaches New 1-Year High - Here's What Happened

Key Points

• Liquidia Technologies' stock reached a new 52-week high of $26.91 during trading with a significant volume of 611,493 shares.
• Analysts have set varying price targets for Liquidia Technologies, with estimates ranging from $31.00 to $43.00, reflecting a general consensus rating of "Moderate Buy."
• Despite a substantial revenue increase of 141.5% year-over-year, the company reported a negative earnings per share of ($0.49), missing analysts' expectations.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report)'s stock price reached a new 52-week high during trading on Monday . The stock traded as high as $26.75 and last traded at $26.91, with a volume of 611493 shares changing hands. The stock had previously closed at $25.95.

Analysts Set New Price Targets

Several equities research analysts have commented on LQDA shares. Wells Fargo & Company raised their price target on shares of Liquidia Technologies from $25.00 to $31.00 and gave the company an "overweight" rating in a research note on Wednesday, August 13th. Jefferies Financial Group reaffirmed a "buy" rating and issued a $43.00 price target on shares of Liquidia Technologies in a research note on Friday. BTIG Research reaffirmed a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Needham & Company LLC boosted their price target on Liquidia Technologies from $32.00 to $36.00 and gave the company a "buy" rating in a research note on Tuesday, August 12th. Finally, Scotiabank raised their price objective on shares of Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research report on Wednesday, May 28th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $31.40.

Liquidia Technologies Stock Performance

The firm has a fifty day simple moving average of $16.30 and a 200 day simple moving average of $15.54. The company has a current ratio of 2.49, a quick ratio of 2.41 and a debt-to-equity ratio of 9.84. The stock has a market cap of $2.36 billion, a price-to-earnings ratio of -16.07 and a beta of 0.14.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Tuesday, August 12th. The company reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.43) by ($0.06). Liquidia Technologies had a negative net margin of 732.17% and a negative return on equity of 232.96%. The firm had revenue of $8.84 million during the quarter, compared to analyst estimates of $3.90 million. The business's revenue for the quarter was up 141.5% compared to the same quarter last year. As a group, sell-side analysts expect that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current year.

Insider Buying and Selling at Liquidia Technologies

In other Liquidia Technologies news, insider Rajeev Saggar sold 2,526 shares of the firm's stock in a transaction dated Monday, July 21st. The shares were sold at an average price of $14.54, for a total transaction of $36,728.04. Following the completion of the transaction, the insider owned 268,887 shares in the company, valued at $3,909,616.98. This trade represents a 0.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Jason Adair sold 2,576 shares of the firm's stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $36,785.28. Following the transaction, the insider owned 193,634 shares of the company's stock, valued at $2,765,093.52. This trade represents a 1.31% decrease in their position. The disclosure for this sale can be found here. Insiders sold 90,277 shares of company stock worth $1,469,392 in the last 90 days. 30.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Liquidia Technologies

A number of hedge funds have recently added to or reduced their stakes in the stock. NewEdge Advisors LLC bought a new stake in Liquidia Technologies during the 2nd quarter worth about $25,000. Hurley Capital LLC acquired a new stake in Liquidia Technologies during the 1st quarter worth $32,000. GAMMA Investing LLC lifted its stake in shares of Liquidia Technologies by 65.6% in the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the period. Steward Partners Investment Advisory LLC lifted its holdings in Liquidia Technologies by 24.0% during the second quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company's stock worth $77,000 after acquiring an additional 1,200 shares in the last quarter. Finally, Summit Investment Advisors Inc. grew its holdings in shares of Liquidia Technologies by 35.0% during the fourth quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company's stock worth $78,000 after buying an additional 1,719 shares in the last quarter. Institutional investors own 64.54% of the company's stock.

About Liquidia Technologies

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.